Table 1 Minimum follow-up durations (in months) and follow-up modalities (C = Clinical, T = Telephone, Q = external request) for the different benign and oncological radiation therapy entities (SRT = Stereotactic radiation therapy, OMD = oligometastatic disease)

Curative primary radiation therapy

C

Q

T

C

Q

Q

C

Definitive RT of primary tumors. e.g. prostate, cervix, meningioma

Curative non-primary radiation therapy

C

T

T

Neo-/ adjuvant / additive RT

Local ablative, non-curative radiation therapy

C

Q

T

Q

Q

Q

Q

Q

Q

Q

Q

e.g. pancreas SBRT

Palliative radiation therapy

T

Q

Symptom control, incl. palliative reirradiation for symptom control

Benign disease

T

T

T

Inflammatory disease: only after 3 months; Ossification prophylaxis: no appointments

OMD, reirradiation – internal aftercare

C

C

C

C

C (16)

C (20)

C

C

C

C

C

C

C

C: incl. PET

OMD, reirradiation - aftercare primarily via referring physicians

C

Q

T

Q

T

Q

T

Q

T

Q

T

C: incl. PET

Brain metastasis SRT – internal aftercare

C

C

C

C

C

C

C

C

C (28)

C (32)

C

C (40)

C (44)

C

C (52)

C (56)

C

Always incl. cMRI

Brain metastasis SRT - aftercare primarily via referring physicians

C

T

Q

T

Q

T

Q

T

Q

T

Q

T

Q

T

Always incl. cMRI

Head and neck tumors

C

Q

Q

C

Q

Q

Q

C

Q

C

Q

Q

Q

Q

Primary RT or adjuvant